Transamerica Financial Advisors’s Jazz Pharmaceuticals JAZZ Stock Holding History

Transamerica Financial Advisors’s Portfolio JAZZ Stock Details JAZZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.89K	Hold	10	–	–	﹤0.01%	1222
2025 Q4	$1.7K	Sell	10 -2	-17%	-$307	﹤0.01%	1160
2025 Q3	$1.58K	Buy	+12	New	+$1.44K	﹤0.01%	1087
2021 Q3	–	Sell	-5	Closed	-$1K	–	163
2021 Q2	$1K	Buy	+5	New	+$866	0.02%	142
2016 Q2	–	Sell	-73	Closed	-$10K	–	551
2016 Q1	$10K	Sell	73 -253	-78%	-$31.5K	﹤0.01%	551
2015 Q4	$46K	Hold	326	–	–	﹤0.01%	416
2015 Q3	$44K	Sell	326 -1,461	-82%	-$252K	﹤0.01%	402
2015 Q2	$315K	Sell	1,787 -34	-2%	-$6.11K	0.02%	282
2015 Q1	$315K	Sell	1,821 -864	-32%	-$148K	0.02%	284
2014 Q4	$440K	Buy	2,685 +910	+51%	+$151K	0.03%	200
2014 Q3	$285K	Sell	1,775 -239	-12%	-$36.7K	0.03%	228
2014 Q2	$297K	Buy	+2,014	New	+$279K	0.03%	237

Other funds holding JAZZ

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Transamerica Financial Advisors's JAZZ Position: Q1 2026 in Review

Transamerica Financial Advisors held its Jazz Pharmaceuticals (JAZZ) position steady in Q1 2026 at 10 shares worth $1.89K. The position accounts for ﹤0.01% of the portfolio, ranked #1222.

Transamerica Financial Advisors first reported a position in JAZZ in Q2 2014 and has held it in 12 quarters since. The position peaked at $440K in Q4 2014. 570 funds tracked by Wall St. Rank hold JAZZ as of Q1 2026.

Transamerica Financial Advisors held 10 shares of Jazz Pharmaceuticals worth $1.89K as of Q1 2026.
Transamerica Financial Advisors left its Jazz Pharmaceuticals share count unchanged in Q1 2026.
Jazz Pharmaceuticals made up ﹤0.01% of Transamerica Financial Advisors's portfolio in Q1 2026, its #1222 holding.
Transamerica Financial Advisors first reported a position in Jazz Pharmaceuticals in Q2 2014 and has held it in 12 quarters since.
Transamerica Financial Advisors's Jazz Pharmaceuticals position peaked at $440K in Q4 2014.
570 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q1 2026.

Based on Transamerica Financial Advisors's 13F filing for Q1 2026, filed 15 May 2026.